24 February 2017

Market Scenario
The market for EMEA cancer biological therapy is increasing rapidly. The major factors that drive the growth of cancer biological therapy are increasing cancer cases, growing demand for advanced therapies, less number of side effects as compared to conventional treatment methods and others.
The market for EMEA cancer biological therapy is expected to grow at the rate of about 5.2% from 2016 to 2021.

Intended Audience
• Cancer Biologics product manufacturers
• Oncology Research Centers
• Research and Development (R&D) Companies
• Government Research Laboratories
• Government and Independent Regulatory Authorities
• Market Research and Consulting Service Providers
• Cancer Research Institutes and Universities

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/616

Key Finding
• Europe accounted for the largest market share of EMEA cancer biological therapy market, registering around $17.0 billion in 2015 and expected to reach at $23.2 billion by 2021.
• Hospitals & Clinics commands maximum share of EMEA cancer biological therapy market in 2015
• Africa Region is expected to grow at a CAGR of 4.7%
• On the basis of types, monoclonal antibodies commands the largest share of around 30% of the total market

Key Players
Some of the key players in this market are: Amgen Inc (US), Bristol-Myers Squibb Company (US), CELGENE CORPORATION (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (SWITZERLAND), Merck & Co., Inc (US), Novartis AG (Switzerland) and others.

Segments
EMEA cancer biological therapy market has been segmented on the basis of phase which comprises of phase I, phase II, and phase III. On the basis of type the market is segmented into monoclonal antibodies, interferon, interleukins, cancer growth inhibitors, gene therapy, colony stimulating factors, targeted therapy, and cancer vaccines. On the basis of end users the market is segmented into hospitals & clinics, cancer research centers, laboratories.

Regional Analysis
Europe is the largest market for cancer biological therapy. The provision of reimbursement for cancer biological therapies is a major factor driving the growth of the market in European countries.
Furthermore Middle East & African region is expected to witness a lucrative growth rate of 4.3% from 2016-2021.

Access Report Details @ https://www.marketresearchfuture.com/reports/cancer-biological-therapy-market

Study Objectives
To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the cancer biological therapy market
• To provide insights about factors affecting the market growth
• To analyze the cancer biological therapy market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Europe, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by phase, by type, by end users and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the regional market.
The report for Cancer Biological Therapy Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors of the market. The report also provides details information and strategies of the top key players in the industry as well as gives a broad study of the different markets segments and regions.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

  • 5k
    Vews
  • 11
    Avg Daily Vews
  • 1 Day
  • 1 Week
  • 1 Month
  • 2 Months
  • 6 Months
  • 1 Year
0 Comments